Companion diagnostics: legislation in progress
By Dr Manja Epping and Steffen Wirsing
In September 2012, the European Commission adopted a proposal for a regulation on in-vitro diagnostic medical devices that included certain specific provisions regarding the classification and conformity assessment of devices used in the context of personalised medicine, so-called companion diagnostics.
Meanwhile, the responsible committee on the environment, public health and food safety (ENVI) published its report. On 22 October, the European Parliament voted on the Commission proposal and the amendments suggested by the committee and agreed on a new proposal that contains some significant changes affecting companion diagnostics.
A companion diagnostic is now defined more precisely as a ‘device specifically intended for and essential to the selection of patients with a previously diagnosed condition or predisposition as suitable or unsuitable for a specific therapy with a medicinal product or a range of medicinal products’…
If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
The OFT finds a significant imbalance of power between ICT suppliers and public sector buyers that prevents effective competition.
The MHRA offers useful guidance on the difference between apps that are regulated as medical devices and those that are related to healthcare but do not qualify.
Analysis from The Lawyer
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world
Financial disputes are starting to dominate the English courts as the long-awaited fallout from the downturn finally comes to town